ATC Group: G01AF05 Econazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G01AF05 in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G01 Gynecological antiinfectives and antiseptics
3 G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
4 G01AF Imidazole derivatives
5 G01AF05 Econazole

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
VAGIN - Vaginal 0.1 g

Active ingredients in G01AF05

Active Ingredient Description
Econazole

Econazole nitrate is a broad spectrum antimycotic with activity against dermatophytes, yeasts and moulds. A clinically relevant action against Gram positive bacteria has also been found.

Related product monographs

Title Information Source Document Type  
GYNO-PEVARYL Vaginal cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
GYNO-PEVARYL Vaginal Pessaries Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PEVARYL Topical cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Estonia (EE)

Ireland (IE)

Israel (IL)

Lithuania (LT)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.